23
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Systemic lupus erythematosus

How to manage, when to refer

, MD & , MD, MPH
Pages 31-40 | Published online: 30 Jun 2015

References

  • Gladman DD, Urowitz MB. Morbidity in systemic lupus erythematosus. J Rheumatol 1987; 14(Supp1 13): 223–6
  • Salmon JE, Roman MJ. Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management. Curr Opin Rheumatol 2001; 13(5): 341–4
  • Uramoto KM, Michet CJ Jr, Thumboo J, et al. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum 1999; 42(1): 46–50
  • McCarty DJ, Manzi S, Medsger TA Jr, et al. Incidence of systemic lupus erythematosus: race and gender differences. Arthritis Rheum 1995; 38(9): 1260–70
  • Boumpas DT, Fessler BJ, Austin HA III, et al. Systemic lupus erythematosus: emerging concepts. Part 2. Dermatologic and joint disease, the anti- phospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Inten Med 1995; 123(1): 42–53
  • Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. (Letter) Arthritis Rheum 1997; 40(9): 1725
  • Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11): 1271–7
  • Klippel J, ed. Primer on the rheumatic diseases. 12th ed. Atlanta: Arthritis Foundation, 1997: 335–6, 339–40, 342
  • Koopman WJ, ed. Arthritis and allied conditions. 14th ed. Baltimore: Lip- pincott Williams & Wilkins, 2001: 1455–71, 1480–92
  • Boumpas DT, Austin HA III, Fessler BJ, et al. Systemic lupus erythematosus: emerging concepts. Part 1. Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med 1995; 122(12): 940–50
  • Manzi S, Meilahn EN, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145(5): 408–15
  • Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 1997; 40(9): 1601–11
  • von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24(5): 323–58
  • Wallace DJ. Antimalarial agents and lupus. Rheum Dis Clin North Am 1994; 20(1): 243–63
  • The Canadian Hydroxy chloroquine Study Group. A randomized study of the effect of withdrawing hydroxy chloroquine sulfate in systemic lupus erythematosus. N Engl J Med 1991; 324(3): 150–4
  • Zonana-Nacach A, Barr SG, Magder LS, et al. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000; 43(8): 1801–8
  • American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for monitoring drug therapy in rheumatoid arthritis. Arthritis Rheum 1996; 39(5): 723–31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.